T

Tempo Scan Pacific Tbk PT
IDX:TSPC

Watchlist Manager
Tempo Scan Pacific Tbk PT
IDX:TSPC
Watchlist
Price: 2 690 IDR -0.74% Market Closed
Market Cap: Rp12.1T

Relative Value

The Relative Value of one TSPC stock under the Base Case scenario is hidden IDR. Compared to the current market price of 2 690 IDR, Tempo Scan Pacific Tbk PT is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TSPC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

TSPC Competitors Multiples
Tempo Scan Pacific Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Tempo Scan Pacific Tbk PT
IDX:TSPC
12.1T IDR 0.9 8.1 4.7 4.7
US
Eli Lilly and Co
NYSE:LLY
947.4B USD 16 51.7 34.8 37.3
US
Johnson & Johnson
NYSE:JNJ
564B USD 6 21 14.6 17.9
CH
Roche Holding AG
SIX:ROG
282B CHF 4.6 30 12.7 14.8
UK
AstraZeneca PLC
LSE:AZN
214.9B GBP 5.1 31.7 15.1 22.1
US
Merck & Co Inc
NYSE:MRK
290.3B USD 4.5 15.2 10.7 12.7
CH
Novartis AG
SIX:NOVN
225.6B CHF 5.2 20.2 12.7 16.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.9 11 12.8
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
145.7B USD 2.3 14.9 7.6 10.4
FR
Sanofi SA
PAR:SAN
98B EUR 1.7 8.2 7.7 7.7
P/E Multiple
Earnings Growth PEG
ID
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Average P/E: 21.7
8.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
51.7
54%
1
US
Johnson & Johnson
NYSE:JNJ
21
6%
3.5
CH
Roche Holding AG
SIX:ROG
30
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.7
38%
0.8
US
Merck & Co Inc
NYSE:MRK
15.2
14%
1.1
CH
Novartis AG
SIX:NOVN
20.2
17%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
15.9
2%
8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
27%
0.6
FR
Sanofi SA
PAR:SAN
8.2
1%
8.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ID
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Average EV/EBITDA: 42.3
4.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.8
34%
1
US
Johnson & Johnson
NYSE:JNJ
14.6
2%
7.3
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
15.1
10%
1.5
US
Merck & Co Inc
NYSE:MRK
10.7
6%
1.8
CH
Novartis AG
SIX:NOVN
12.7
6%
2.1
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
FR
Sanofi SA
PAR:SAN
7.7
8%
1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
ID
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Average EV/EBIT: 90.2
4.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.3
37%
1
US
Johnson & Johnson
NYSE:JNJ
17.9
6%
3
CH
Roche Holding AG
SIX:ROG
14.8
6%
2.5
UK
AstraZeneca PLC
LSE:AZN
22.1
23%
1
US
Merck & Co Inc
NYSE:MRK
12.7
8%
1.6
CH
Novartis AG
SIX:NOVN
16.4
12%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
7%
1.5
FR
Sanofi SA
PAR:SAN
7.7
6%
1.3